verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: sagent pharmaceuticals
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler sagent pharmaceuticals
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

verapamil hydrochloride 2.5 mg/mL

Manufacturer
Sagent Pharmaceuticals

Identifiers & Regulatory

Product NDC 25021-312
Product ID 25021-312_b4eb5dd2-5e25-4ecc-ac57-8897f2b6984a
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA214361
Listing Expiration 2026-12-31
Marketing Start 2021-03-15

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 25021312
Hyphenated Format 25021-312

Supplemental Identifiers

RxCUI
1665057 1665061
UNII
V3888OEY5R

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA214361 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 2.5 mg/mL
source: ndc
Packaging
  • 25 VIAL in 1 CARTON (25021-312-02) / 2 mL in 1 VIAL
  • 5 VIAL in 1 CARTON (25021-312-04) / 4 mL in 1 VIAL
source: ndc

Packages (2)

25021-312-02 25 VIAL in 1 CARTON (25021-312-02) / 2 mL in 1 VIAL 25021-312-04 5 VIAL in 1 CARTON (25021-312-04) / 4 mL in 1 VIAL

Ingredients (1)

verapamil hydrochloride (2.5 mg/mL)

Linked Drug Pages (1)

Verapamil Hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "b4eb5dd2-5e25-4ecc-ac57-8897f2b6984a", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["1665057", "1665061"], "spl_set_id": ["a76b2cff-7029-4607-88db-9921ec2842b6"], "manufacturer_name": ["Sagent Pharmaceuticals"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "25 VIAL in 1 CARTON (25021-312-02)  / 2 mL in 1 VIAL", "package_ndc": "25021-312-02", "marketing_start_date": "20210315"}, {"sample": false, "description": "5 VIAL in 1 CARTON (25021-312-04)  / 4 mL in 1 VIAL", "package_ndc": "25021-312-04", "marketing_start_date": "20210315"}], "brand_name": "Verapamil Hydrochloride", "product_id": "25021-312_b4eb5dd2-5e25-4ecc-ac57-8897f2b6984a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "25021-312", "generic_name": "Verapamil Hydrochloride", "labeler_name": "Sagent Pharmaceuticals", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Verapamil Hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "2.5 mg/mL"}], "application_number": "ANDA214361", "marketing_category": "ANDA", "marketing_start_date": "20210315", "listing_expiration_date": "20261231"}